💡 Company acquiring additional 24% stake to make subsidiary wholly owned for brand consolidation and product expansion.
What Happened
Sat Kartar Life Limited (formerly Sat Kartar Shopping Limited) has announced that its Board of Directors approved the acquisition of an additional 24% stake in its subsidiary, Plantomed Nutraceuticals Private Limited. This transaction will make Plantomed a wholly owned subsidiary of Sat Kartar Life. The acquisition is expected to be completed by May 15, 2026, for a cash consideration of ₹1.21 crore.
Key Details
- Company: Sat Kartar Life Limited
- Event Type: M&A
- Filing Date: 18-Apr-2026 18:59:41
- NSE Filing: View Document
Why It Matters
This acquisition allows Sat Kartar Life to gain full 100% control over Plantomed Nutraceuticals, which operates in the Ayurveda healthcare and nutraceuticals space. The company states this move will enable better brand consolidation, align operations with its long-term vision, and support product expansion. Taking full ownership of a subsidiary can streamline decision-making and integrate operations more effectively, potentially creating synergies within the group.
Disclaimer: This is publicly available information sourced from NSE. Not investment advice.
Get signals like this instantly
Free Telegram alerts within 2 minutes of NSE filing
Join SuperStock Free